Dyslipidemia: the risc factor of aortic stenosis by Dodul, Cristina & Vetrilă, Snejana
DYSLIPIDEMIA: THE RISC FACTOR OF AORTIC STENOSIS
Introduction 
Purpose
We conducted a transversal, prospective study that included 46 patients with a
diagnosis of aortic stenosis confirmed by echocardiography. Patients were examined
according to a questionnaire, which included general data and lipid profile parameters.
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Aortic stenosis (SA) is the most common valvular heart disease and the third
cardiovascular disease after hypertension and coronary heart disease in Western
countries. There is currently no definite medical treatment that can delay or stop the
progression of the disease. Therefore, risk assessment is needed to develop new
strategies to prevent and slow the progression of the disease.
Aortic stenosis, dyslipidemia, atherogenic index, non-HDL cholesterol 
Evaluation of lipid profile and atherogenic index of plasma in patients with aortic stenosis
to optimize treatment.
The mean age of the group was 64.3 ± 0.03 years. Evaluation of risk factors found
hypertension in 28 (60.8%) cases, obesity - 33 (71.7%), dyslipidemia-18 (39.1%).
Evaluation of the lipidogram showed a high level of total cholesterol in 18 (39.1%) cases,
LDL-cholesterol - 13 (28.2%), triglycerides in 9 (19.5%) cases, and a low level of HDL
was attested in 14 (30.4%) cases. Ideal values of non-HDL cholesterol (<3.4 mmol / l)
were obtained in 17 (36.9%) patients. IAP indicated a moderate risk of developing
atherosclerosis in 10 (21.7%) and an increased risk - in 6 (13.0%) cases.
Dyslipidemia is common in patients with aortic stenosis, being attested in 39.1% of
cases, and the atherogenic index of plasma with an increased risk of developing
atherosclerosis in 34.7% of cases. Therefore the control of the lipid profile in aortic
stenosis is essential in management of these patients.
General characteristic of patients in the study group
Criterii Lotul I, Stenoza aortică minimală 
și moderată N=29 
Lotul II, Stenoza aortică severă
N=17 




























Deviations in the lipidogram in patients in the study group
Distribution of IAP by severity in patients in the study group
Distribution of patients according to BMI
Material and methods
